GAMMA Investing’s Beta Bionics BBNX Stock Holding History

GAMMA Investing’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.7K	Buy	511 +25	+5%	+$449	﹤0.01%	3352
2026 Q2	$7.62K	Sell	486 -108	-18%	-$1.28K	﹤0.01%	3317
2026 Q1	$5.95K	Sell	594 -185	-24%	-$2.74K	﹤0.01%	3301
2025 Q4	$23.7K	Buy	779 +155	+25%	+$4.14K	﹤0.01%	2521
2025 Q3	$12.4K	Buy	624 +87	+16%	+$1.53K	﹤0.01%	2776
2025 Q2	$7.82K	Buy	537 +524	+4,031%	+$7.42K	﹤0.01%	2930
2025 Q1	$159	Buy	+13	New	+$242	﹤0.01%	3766

Other funds holding BBNX

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's BBNX Position: Q3 2026 in Review

GAMMA Investing increased its Beta Bionics (BBNX) stake by 5.1% in Q3 2026, buying an estimated $449 and bringing the position to 511 shares worth $9.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3352.

GAMMA Investing first reported a position in BBNX in Q1 2025 and has held it in 7 quarters since. The position peaked at $23.7K in Q4 2025. 4 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

GAMMA Investing held 511 shares of Beta Bionics worth $9.7K as of Q3 2026.
GAMMA Investing bought 25 Beta Bionics shares in Q3 2026, an estimated $449.
Beta Bionics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3352 holding.
GAMMA Investing first reported a position in Beta Bionics in Q1 2025 and has held it in 7 quarters since.
GAMMA Investing's Beta Bionics position peaked at $23.7K in Q4 2025.
4 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.